SMC green light for rare blood cancer treatment
NHS funding was backed for four medicines
Read More
Tag: lusutrombopag
Lusutrombopag gets EU green light for liver disease
Marketing authorisation in the EU has been granted for Shionogi’s lusutrombopag in severe thrombocytopenia.
Read More
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
- eXmoor Pharma and UCL establish strategic cell and gene therapy collaboration
